DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Tuesday 17 May 2016

Michal Shavit

Michal Shavit.

Michal Shavit

Research Scientist at On Target Chemistry Israel




LINJKS\
On Target Chemistry official opening

Experience

Research Scientist

On Target Chemistry from the Recipharm group
 – Present (8 months)Ness Ziona, Israel

Postdoctoral Researcher

Technion - Israel Institute of Technology
 –  (8 months)Haifa

Research Assistant

Columbia University
 –  (1 year 1 month)

Education

Technion - Israel Institute of Technology

Doctor of Philosophy (PhD), Chemistry

The Hebrew University

Master of Science (MSc), Chmistry

The Hebrew University of Jerusalem

Bachelor’s Degree, Chmistry

Publications

Active cytotoxic reagents based on non-metallocene non-diketonato well-defined C2-symmetrical titanium complexes of tetradentate bis(phenolato) ligands(Link)

J. Am. Chem. Soc.
September 18, 2007
A new family of non-Cp-based non-diketonato-based C2-symmetrical octahedral Ti(IV) complexes of dianionic diamine bis(phenolato) ligands, which are conveniently obtained as single isomers in quantitative yields, leads to appreciable cytotoxicity against colon and ovarian cells with a non-transferrin-dependent cell penetration mechanism. The ligand structural features including steric demands,...more

Structural characterization of dinuclear Ti(IV) complexes of rigid tetradentate dianionic diamine bis(phenolato) ligands; effect of steric bulk on coordination features(Link)

Journal of Organometallic Chemistry
October 4, 2008
A small difference in diamine bis(phenolato) ligands, namely an additional single methylene unit, directs formation of dinuclear Ti(IV) complexes rather than mononuclear ones as characterized by X-ray crystallography. Varying steric bulk of the ligand affects the coordination number in the dinuclear complexes and the ligand to metal ratio. A ligand with reduced steric bulk leads to a L2Ti2(OiPr)4...more

Antitumor Reactivity of Non-Metallocene Titanium Complexes of Oxygen-Based Ligands: is Ligand Lability Essential?(Link)

J. Biol. Inorg. Chem.
July 2007
In our attempt to define the parameters affecting anticancer activity of titanium complexes and to assess the role of hydrolytic stability, titanium compounds of oxygen-based ligands were studied. A homoleptic complex of hydroxyamino-1,3,5-triazine ligands was prepared and its hydrolysis was investigated by UV–vis spectroscopy at biologically relevant pH and temperature conditions based on its...more
4 authors
  • Michal Shavit
    Michal Shavit
    Research Scientist at On Target Chemistry Israel
  • Dani Peri
    Dani Peri
    Materials and Inorganic Chemist
  • No photo
    Artem Melman
  • No photo
    Edit Y. Tshuva

Preparation and X-Ray Structures of Ti(IV) Complexes of Bis(carboxylato) Ligands; Formation of Mono-, Di-, Tetra- and Hexanuclear Complexes With or Without OR and μ-O Ligands

Eur. J. Inorg. Chem.
2008
2 authors

Synthesis, Characterization, Cytotoxicity, and Hydrolytic Behavior of C2 and C1-Symmetrical Ti(IV) Complexes of Tetradentate Diamine Bis(Phenolato) Ligands: A New Class of Antitumor Agents

Chem. Eur. J
2009

TiIV Complexes of Branched Diamine Bis(phenolato) Ligands: Hydrolysis and Cytotoxicity

Eur. J. Inorg. Chem.
2011

Increased Selectivity toward Cytoplasmic versus Mitochondrial Ribosome Confers Improved Efficiency of Synthetic Aminoglycosides in Fixing Damaged Genes: A Strategy for Treatment of Genetic Diseases Caused by Nonsense Mutations

Journal of Medicinal Chemistry
2012

Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations

ACS Medicinal Chemistry Letters
February 8, 2016







///////

No comments:

Post a Comment